☆ 4.4 Meeting Abstract

In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)

Add to Collection

Journal

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Volume 25, Issue -, Pages 6-7

Publisher

JOHN WILEY & SONS LTD

Keywords

-

Categories

Immunology Infectious Diseases

Funding

  1. NIAID [HHSN272201500032C]
  2. NCI [75N91019D00024]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.